Vitatex Inc. (Vitatex) is a biotechnology company engaged in the commercialization of immunochemistry test reagents for the in-vitro diagnostic markets. The product portfolio of the company includes Vita-Assays, Vita-Cap, tumor angiogenesis and metastasis monoclonal antibodies. Vita-Cap is a series of blood collection tubes that is developed through its proprietary cell adhesion matrices to preserve the quality of cancer and angiogenic cells in a blood sample. Its Vita-Assay is a cell culture plate formulated using its proprietary cell adhesion matrices (CAM) to capture and preserve viable rare circulating cells. The company launched a new series of Vita-Cap F products which enriches the functioning of human tumor and other rare viable cells from whole blood, bone marrow, lymph and other body fluids. Vitatex is headquartered in New York, the US.